$Atomo (ASX: $AT1) has received an additional unscheduled purchase order to supply a further 422,000 integrated blood test devices for the rapid blood based testing of antibodies produced in response to #Covid_19. https://t.co/P5sYwhDbnJ. #TestKit #virus #ASX #healthcare  #stocks https://t.co/rLrXWGcRNR